Researchers have applied RT-ddPCR to measure clinically relevant exRNAs like androgen receptor splice variant 7 (AR-V7) mRNA in exosomes of prostate cancer patients, detecting this therapy-resistance marker in plasma with high sensitivity [88]. Here, AR is linked to prostate carcinoma.